Praxis Precision Medicines (NASDAQ:PRAX): A Wild Rollercoaster Ride

TipRanksMay 22 03:58 ET

Analysts' Top Healthcare Picks: Praxis Precision Medicines (PRAX), Corbus Pharmaceuticals (CRBP)

TipRanksMay 20 06:32 ET

Praxis Precision Medicines to Participate in Upcoming Investor Conferences

BOSTON, May 17, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ:PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous

GlobeNewswireMay 17 08:00 ET

Express News | Truist Securities Maintains Buy on Praxis Precision Medicine, Maintains $150 Price Target

BenzingaMay 16 13:22 ET

Buy Rating Backed by Robust Pipeline and Market Opportunity for Praxis Precision Medicines

TipRanksMay 16 04:19 ET

Express News | HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $105 Price Target

BenzingaMay 14 07:47 ET